At BD, we believe that people are at the heart of every breakthrough, solution, and step forward. Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. We know that possibilities are endless when people feel supported and inspired. From our robust benefits to our inclusive, growth-focused culture, we’re here to help you thrive both professionally and personally.
world of health™
1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan. 2022 BD becomes the first company to combine flow cytometry with fluorescence imaging and image-based decisioning to sort individual cells based on visual details of the cell at exceptionally high speed (15,000 cells per second). 1 Reflects comparable FY24 revenue, adjusted for a full year of Advanced Patient Monitoring revenue generated during Edwards Lifesciences’ ownership. Please be aware of potentially fraudulent job postings on other websites or suspicious recruiting email or text messages that attempt to collect your confidential information.
BD Integrated Diagnostic Solutions
In addition, excluded from adjusted EBIDTA margin are certain costs that BD does not allocate to its organizational units, such as, among other things, foreign exchange, certain general and administrative expenses, and share based compensation expense. BD does not attempt to provide reconciliations of forward-looking adjusted EBITDA margin to the comparable GAAP measure because the impact and timing of these potential charges or gains are inherently uncertain and difficult to predict and are unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a material impact on GAAP measures of the Biosciences and Diagnostic Solutions business’s financial performance.
Help advance care for patients throughout their diagnostic journey, while also addressing your testing needs
A bloodstream infection (BSI) can lead to a dysregulated immune response if untreated. To make substantial improvements to BSI testing, consider the entire diagnostic pathway – from blood culture collection to result. It has advanced fluorescence detection technology, exceptional media performance and instrument reliability—adding vial-activated workflow, advanced ergonomics, blood culture observation and customer-focused data management. The easy-to-use workflow comes in a compact, modular design, which can be adapted to multiple space- and time-saving configurations for your laboratory staff. From collecting specimens to reporting results, the diagnostic pathway has multiple points, each with the potential to optimize efficiencies and advance the quality of patient care. BD offers a comprehensive portfolio of integrated solutions designed to help your facility elevate the patient experience and position your lab as a vital resource, rather than a necessary cost center.
BD and more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
After the separation, the New BD is expected to have fiscal 2024 revenue of approximately $17.8 billion1, with a $70+ billion addressable market growing at approximately 5%. New BD is expected to benefit from strong, durable cash flow and a best-in-class recurring revenue profile of over 90% that will help drive focused investment, accelerate New BD’s innovation pipeline and systematically enhance growth and margin targets. Post-separation, New BD intends to focus on maintaining a strong balance sheet, making investments in innovation, returning capital to shareholders via dividend and share repurchases, and maintaining Casino Betinwin its investment grade credit rating. The BD Life Sciences segment delivers innovative solutions from discovery to diagnosis, continually advancing science and clinical outcomes across infectious disease and cancer. Offerings include preanalytical solutions for sample management; immunology research solutions, including flow cytometry and multiomics tools; microbiology and molecular diagnostics; lab automation and informatics solutions; and differentiated reagents and assays.
Together We Advance
98% of hospital inpatients undergo some form of diagnostic testing.1 Diagnostic tests for blood culture, blood chemistry and urine affect nearly every patient in your facility. And while ensuring patient care is your primary priority, you may also face other challenges such as complex tests, suboptimal workflows, preanalytical errors and staffing shortages. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement.
By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at /company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers.